Twist Bioscience Corporation (TWST) Quote

TWST under $50

TWST is volatile but the trend remains bullish

TWST new 52 week high

TWST over $30

TWST new 52 week high

$TWST Markets down,,Twist is up!!

Twist Bioscience Corp NASDAQ: TWST

GoSymbol lookup
Health Care : Biotechnology | Small Cap GrowthCompany profile
Twist Bioscience Corporation is a synthetic biology company. The Company has developed a disruptive DNA synthesis platform. The core of its platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by writing DNA on a silicon chip. The Company utilizes its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for sample preparation and antibody libraries for drug discovery and development. The Company's product lines, synthetic biology tools and NGS tools, addresses different needs of its customers across a range of applications, such as synthetic genes, oligo pools, SARS-CoV-2 tools, and DNA libraries. Its synthetic biology products include Synthetic genes and gene fragments, Oligonucleotide, or Oligo pools for CRISPR gene editing. The NGS products are used for diagnostic tests for various indications like SARS-CoV-2.

TWST (own it)

That awful Cathie Wood has been buying

Twist shareholders who have held company stock since before December 13, 2019, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award at no cost to them whatsoever.

https://grabarlaw.com/the-latest/twist-bioscience-shareholder-investigation/

It is alleged, in several class actions, that the Company and certain of its officers overstated the commercial viability of Twist Bioscience’s synthetic DNA manufacturing technology while engaging in accounting fraud and using unsustainable pricing to inflate Twist Bioscience’s true financial condition and prospects.

Unlike a class action, brought on behalf of investors, a shareholder derivative action or demand is brought by a shareholder of a public company on behalf of and for the benefit of the company itself. In a derivative action, shareholders “step into the shoes” of the directors and officers of a company and bring litigation that the board would be unwilling to pursue on its own. Shareholder derivative litigation can recover damages back to the company for financial or reputational harm caused by the conduct of its insiders, and also can be used to improve the governance of public companies in order to guard against such harms in the future.

Yes

Do you still hold TWST shares?

It is hard to believe that 95% of the outstanding shares are owned by institutions!!!!! That only leaves 5% for the rest of us little people to fight over.... it is going to get very expensive, very quickly, to get in if you are not in already!!!!

This should be a good ride to be on!

Got in today. Twist chips can store 10,000x more data on a chip than any other technique. That’s just one of their revenue streams Second: They are storing data IN DNA now!! Not science fiction. Third: they have all the DNA sequences!! Why sell them!! They are going to be developing drugs for everything from covid to cancer. Adding n dips. Good luck to all.

nice run-up for TWST this last year...looks like it went too high, panic sale today chopped all that gain...

Synthetic DNA Technology is gonna Change the World as we know it!!



$$TWST

Rumor from the yacht rock bands docking at The Canery is we’re $40 we tap this week.

$30 is the Support Level for TWST

I'm new here with TWST! Is TWST in a court battle??

Any proof of this??

What's pending here!!??

Good Company Here!!

Less than 9,000 shares traded all day so far? And lost 71 million on 25 million revenues last year? This company has a long ways to go to convince investors they are a viable alternative to the multitude of other investments out there. Somebody convince me otherwise. Please?

I think TWST could pull a TLRY, it definetly has the MOMO.

Ilumina bought Pacific biosciences recently for 1.2 billion. I believe TWST is already a buyout target for the big boys.

Great call observer21. I think were looking at a buyout when the lawsuit problems are settled.

Now that I've had more time to do due diligence, I'm more cautious. "Ginkgo Bioworks also accounted for 40% and 32% of our revenue for the nine months ended June 30, 2017 and 2018, respectively." ....Negative gross margins. ....and IR was unhelpful and dismissive of my questions...A vibe I personally cannot ignore. Entirely possible they were just having a bad day.
Good DD.... https://www.nanalyze.com/2018/10/twist-bioscience-stock-ipo/

Anyone have any knowledge concerning the Agilent lawsuit...timelines, Etc?

This company could be a blockbuster. Very exciting technology and a first mover.